[The treatment of benign processes of the cervix uteri associated with papillomavirus infection in women who have not given birth].
A method is suggested for treatment of benign processes of uterine cervix, associated with papillomavirus infection, in nonparous women. The method consists in applying glycerin to the mucous membrane of the vulva and vagina for 10 to 12 days before local application of 5-fluorouracilum, and use of vaginal suppositories plus interferon alpha-2 beta following the course of treatment with cytostatics. The proposed treatment modality proved to be highly effective for the above conditions.
Lakatosh
V P
VP
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D005990:Glycerol / Q000008:administration & dosage; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000188:drug therapy*; D010298:Parity; D010570:Pessaries; D011994:Recombinant Proteins; D013997:Time Factors; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000188:drug therapy*; D002577:Uterine Cervical Diseases / Q000175:diagnosis / Q000188:drug therapy*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D005990:Glycerol; D005472:Fluorouracil